“Comparing Methods For Calculating Confidence Intervals For Vaccine Efficacy.”. Stat Med 15 (21-22). Stat Med: 2379-92. doi:10.1002/(SICI)1097-0258(19961115)15:21<2379::AID-SIM457>3.0.CO;2-L.
. 1996. “The Large Sample Distribution Of The Weighted Log Rank Statistic Under General Local Alternatives.”. Lifetime Data Anal 3 (1). Lifetime Data Anal: 5-12. doi:10.1023/a:1009690200504.
. 1997. “Risk Factors Associated With Preeclampsia In Healthy Nulliparous Women. The Calcium For Preeclampsia Prevention (Cpep) Study Group.”. Am J Obstet Gynecol 177 (5). Am J Obstet Gynecol: 1003-10. doi:10.1016/s0002-9378(97)70004-8.
. 1997. “Prednisone Withdrawal In Kidney Transplant Recipients On Cyclosporine And Mycophenolate Mofetil--A Prospective Randomized Study. Steroid Withdrawal Study Group.”. Transplantation 68 (12). Transplantation: 1865-74. doi:10.1097/00007890-199912270-00009.
. 1999. “Prednisone Withdrawal In Kidney Transplant Recipients On Cyclosporine And Mycophenolate Mofetil - A Prospective Randomized Study”. Transplantation 12. Transplantation: 1865-74.
. 1999. “No Evidence For Lipid Peroxidation In Severe Preeclampsia”. Am J Obstet Gynecol 185. Am J Obstet Gynecol: 572-8.
. 2001. “Economic Analysis Of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial Of T-Cell Depletion Vs Unmanipulated Grafts For The Prevention Of Graft-Versus-Host Disease”. Bone Marrow Transplant 36. Bone Marrow Transplant: 539-546. http://www.ncbi.nlm.nih.gov/pubmed/16044144.
. 2005. “Economic Analysis Of Unrelated Allogeneic Bone Marrow Transplantation: Results From The Randomized Clinical Trial Of T-Cell Depletion Vs Unmanipulated Grafts For The Prevention Of Graft-Versus-Host Disease.”. Bone Marrow Transplant 36 (6). Bone Marrow Transplant: 539-46. doi:10.1038/sj.bmt.1705078.
. 2005. “The Effect Of Unrelated Donor Marrow Transplantation On Health-Related Qualify Of Life: A Report Of The Unrelated Donor Marrow Transplantation Trial (T-Cell Depletion Trial)”. Biol Blood Marrow Transplant 12. Biol Blood Marrow Transplant: 648-655. http://www.ncbi.nlm.nih.gov/pubmed/16737938.
. 2006. . 2007.
“Autologous Vs. Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation For Patients With Follicular Non-Hodgkins Lymphoma (Fl) Beyond First Complete Response Or First Partial Response”. In American Society Of Clinical Oncology Annual Meeting. American Society Of Clinical Oncology Annual Meeting. Chicago, IL. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_meeting_categories_view&confID=55.
. 2008. “Use Of Biological Assignment In Hematopoietic Stem Cell Transplantation Clinical Trials”. Clin Trials 5. Clin Trials: 607-616. http://www.ncbi.nlm.nih.gov/pubmed/19029209.
. 2008. “Autologous Vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation For Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response Or First Partial Response”. Biol Blood Marrow Transplant 17. Biol Blood Marrow Transplant: 1051-1057. http://www.ncbi.nlm.nih.gov/pubmed/21073974.
. 2011. “Fludarabine-Based Conditioning For Marrow Transplantation From Unrelated Donors In Severe Aplastic Anemia: Early Results Of A Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events At Predefined Cyclophosphamide Dose Levels”. Biol Blood Marrow Transplant 18. Biol Blood Marrow Transplant: 1007-1011. http://www.ncbi.nlm.nih.gov/pubmed/22546497.
. 2012. “Correlate Of Immune Protection Against Hsv-1 Genital Disease In Vaccinated Women”. J Infect Dis 209. J Infect Dis: 828-836. http://www.ncbi.nlm.nih.gov/pubmed/24285844.
. 2014. “Hsv-1 And Hsv-2 Seroprevalence In The United States Among Asymptomatic Women Unaware Of Any Herpes Simplex Virus Infection (Herpevac Trial For Women)”. Southern Medical Journal 107. Southern Medical Journal: 79-84. http://www.ncbi.nlm.nih.gov/pubmed/24926671.
. 2014.